Skip to main content
PMC home page
Gut logoLink to Gut
. 1996 Jul;39(1):1–4. doi: 10.1136/gut.39.1.1

Hydrogen sulphide: a bacterial toxin in ulcerative colitis?

M C Pitcher 1, J H Cummings 1
PMCID: PMC1383219  PMID: 8881797

Full text

PDF
1

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ardawi M. S., Newsholme E. A. Fuel utilization in colonocytes of the rat. Biochem J. 1985 Nov 1;231(3):713–719. doi: 10.1042/bj2310713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ationu A., Sorensen K., Whitehead B., Singer D., Carter N. Ventricular expression and circulating levels of immunoreactive dynorphin in heart transplant recipients. Clin Sci (Lond) 1993 Jul;85(1):1–4. doi: 10.1042/cs0850001. [DOI] [PubMed] [Google Scholar]
  3. Beerens H., Romond C. Sulfate-reducing anaerobic bacteria in human feces. Am J Clin Nutr. 1977 Nov;30(11):1770–1776. doi: 10.1093/ajcn/30.11.1770. [DOI] [PubMed] [Google Scholar]
  4. Butine T. J., Leedle J. A. Enumeration of selected anaerobic bacterial groups in cecal and colonic contents of growing-finishing pigs. Appl Environ Microbiol. 1989 May;55(5):1112–1116. doi: 10.1128/aem.55.5.1112-1116.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. COLEMAN G. S. A sulphate-reducing bacterium from the sheep rumen. J Gen Microbiol. 1960 Apr;22:423–436. doi: 10.1099/00221287-22-2-423. [DOI] [PubMed] [Google Scholar]
  6. Carli T., Diker K. S., Eyigor A. Sulphate-reducing bacteria in bovine faeces. Lett Appl Microbiol. 1995 Oct;21(4):228–229. doi: 10.1111/j.1472-765x.1995.tb01047.x. [DOI] [PubMed] [Google Scholar]
  7. Chapman M. A., Grahn M. F., Boyle M. A., Hutton M., Rogers J., Williams N. S. Butyrate oxidation is impaired in the colonic mucosa of sufferers of quiescent ulcerative colitis. Gut. 1994 Jan;35(1):73–76. doi: 10.1136/gut.35.1.73. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Christl S. U., Gibson G. R., Cummings J. H. Role of dietary sulphate in the regulation of methanogenesis in the human large intestine. Gut. 1992 Sep;33(9):1234–1238. doi: 10.1136/gut.33.9.1234. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cooke E. M. A quantitative comparison of the faecal flora of patients with ulcerative colitis and that of normal persons. J Pathol Bacteriol. 1967 Oct;94(2):439–444. doi: 10.1002/path.1700940225. [DOI] [PubMed] [Google Scholar]
  10. Cummings J. H., Pomare E. W., Branch W. J., Naylor C. P., Macfarlane G. T. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut. 1987 Oct;28(10):1221–1227. doi: 10.1136/gut.28.10.1221. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Cummings J. H. Short chain fatty acids in the human colon. Gut. 1981 Sep;22(9):763–779. doi: 10.1136/gut.22.9.763. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Eade M. N., Brooke B. N. Portal bacteraemia in cases of ulcerative colitis submitted to colectomy. Lancet. 1969 May 17;1(7603):1008–1009. doi: 10.1016/s0140-6736(69)91802-9. [DOI] [PubMed] [Google Scholar]
  13. Florin T. H. Hydrogen sulphide and total acid-volatile sulphide in faeces, determined with a direct spectrophotometric method. Clin Chim Acta. 1991 Feb 15;196(2-3):127–134. doi: 10.1016/0009-8981(91)90065-k. [DOI] [PubMed] [Google Scholar]
  14. Florin T., Neale G., Gibson G. R., Christl S. U., Cummings J. H. Metabolism of dietary sulphate: absorption and excretion in humans. Gut. 1991 Jul;32(7):766–773. doi: 10.1136/gut.32.7.766. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Fox J. G., Dewhirst F. E., Fraser G. J., Paster B. J., Shames B., Murphy J. C. Intracellular Campylobacter-like organism from ferrets and hamsters with proliferative bowel disease is a Desulfovibrio sp. J Clin Microbiol. 1994 May;32(5):1229–1237. doi: 10.1128/jcm.32.5.1229-1237.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Gardiner K. R., Halliday M. I., Barclay G. R., Milne L., Brown D., Stephens S., Maxwell R. J., Rowlands B. J. Significance of systemic endotoxaemia in inflammatory bowel disease. Gut. 1995 Jun;36(6):897–901. doi: 10.1136/gut.36.6.897. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Gebhart C. J., Barns S. M., McOrist S., Lin G. F., Lawson G. H. Ileal symbiont intracellularis, an obligate intracellular bacterium of porcine intestines showing a relationship to Desulfovibrio species. Int J Syst Bacteriol. 1993 Jul;43(3):533–538. doi: 10.1099/00207713-43-3-533. [DOI] [PubMed] [Google Scholar]
  18. Giaffer M. H., Holdsworth C. D., Duerden B. I. The assessment of faecal flora in patients with inflammatory bowel disease by a simplified bacteriological technique. J Med Microbiol. 1991 Oct;35(4):238–243. doi: 10.1099/00222615-35-4-238. [DOI] [PubMed] [Google Scholar]
  19. Gibson G. R., Cummings J. H., Macfarlane G. T., Allison C., Segal I., Vorster H. H., Walker A. R. Alternative pathways for hydrogen disposal during fermentation in the human colon. Gut. 1990 Jun;31(6):679–683. doi: 10.1136/gut.31.6.679. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Gibson G. R., Cummings J. H., Macfarlane G. T. Competition for hydrogen between sulphate-reducing bacteria and methanogenic bacteria from the human large intestine. J Appl Bacteriol. 1988 Sep;65(3):241–247. doi: 10.1111/j.1365-2672.1988.tb01891.x. [DOI] [PubMed] [Google Scholar]
  21. Gibson G. R., Cummings J. H., Macfarlane G. T. Use of a three-stage continuous culture system to study the effect of mucin on dissimilatory sulfate reduction and methanogenesis by mixed populations of human gut bacteria. Appl Environ Microbiol. 1988 Nov;54(11):2750–2755. doi: 10.1128/aem.54.11.2750-2755.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Gibson G. R., Macfarlane G. T., Cummings J. H. Occurrence of sulphate-reducing bacteria in human faeces and the relationship of dissimilatory sulphate reduction to methanogenesis in the large gut. J Appl Bacteriol. 1988 Aug;65(2):103–111. doi: 10.1111/j.1365-2672.1988.tb01498.x. [DOI] [PubMed] [Google Scholar]
  23. Gibson G. R. Physiology and ecology of the sulphate-reducing bacteria. J Appl Bacteriol. 1990 Dec;69(6):769–797. doi: 10.1111/j.1365-2672.1990.tb01575.x. [DOI] [PubMed] [Google Scholar]
  24. Granlund-Edstedt M., Johansson E., Claesson R., Carlsson J. Effect of anaerobiosis and sulfide on killing of bacteria by polymorphonuclear leukocytes. J Periodontal Res. 1993 Sep;28(5):346–353. doi: 10.1111/j.1600-0765.1993.tb01078.x. [DOI] [PubMed] [Google Scholar]
  25. Huisingh J., McNeill J. J., Matrone G. Sulfate reduction by a Desulfovibrio species isolated from sheep rumen. Appl Microbiol. 1974 Sep;28(3):489–497. doi: 10.1128/am.28.3.489-497.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Kadota H., Ishida Y. Production of volatile sulfur compounds by microorganisms. Annu Rev Microbiol. 1972;26:127–138. doi: 10.1146/annurev.mi.26.100172.001015. [DOI] [PubMed] [Google Scholar]
  27. Kandylis K. Toxicology of sulfur in ruminants: review. J Dairy Sci. 1984 Oct;67(10):2179–2187. doi: 10.3168/jds.S0022-0302(84)81564-7. [DOI] [PubMed] [Google Scholar]
  28. Kühn R., Löhler J., Rennick D., Rajewsky K., Müller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell. 1993 Oct 22;75(2):263–274. doi: 10.1016/0092-8674(93)80068-p. [DOI] [PubMed] [Google Scholar]
  29. Lauritsen K., Hansen J., Bytzer P., Bukhave K., Rask-Madsen J. Effects of sulphasalazine and disodium azodisalicylate on colonic PGE2 concentrations determined by equilibrium in vivo dialysis of faeces in patients with ulcerative colitis and healthy controls. Gut. 1984 Nov;25(11):1271–1278. doi: 10.1136/gut.25.11.1271. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Macfarlane G. T., Gibson G. R., Cummings J. H. Comparison of fermentation reactions in different regions of the human colon. J Appl Bacteriol. 1992 Jan;72(1):57–64. doi: 10.1111/j.1365-2672.1992.tb04882.x. [DOI] [PubMed] [Google Scholar]
  31. Marcus R., Watt J. Seaweeds and ulcerative colitis in laboratory animals. Lancet. 1969 Aug 30;2(7618):489–490. doi: 10.1016/s0140-6736(69)90187-1. [DOI] [PubMed] [Google Scholar]
  32. Marcus R., Watt J. Ulcerative disease of the colon in laboratory animals induced by pepsin inhibitors. Gastroenterology. 1974 Sep;67(3):473–483. [PubMed] [Google Scholar]
  33. Mardini H. A., Lindsay D. C., Deighton C. M., Record C. O. Effect of polymer coating on faecal recovery of ingested 5-amino salicylic acid in patients with ulcerative colitis. Gut. 1987 Sep;28(9):1084–1089. doi: 10.1136/gut.28.9.1084. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. McOrist S., Jasni S., Mackie R. A., MacIntyre N., Neef N., Lawson G. H. Reproduction of porcine proliferative enteropathy with pure cultures of ileal symbiont intracellularis. Infect Immun. 1993 Oct;61(10):4286–4292. doi: 10.1128/iai.61.10.4286-4292.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. McOrist S., Lawson G. H. Reproduction of proliferative enteritis in gnotobiotic pigs. Res Vet Sci. 1989 Jan;46(1):27–33. [PubMed] [Google Scholar]
  36. Ng W., Tonzetich J. Effect of hydrogen sulfide and methyl mercaptan on the permeability of oral mucosa. J Dent Res. 1984 Jul;63(7):994–997. doi: 10.1177/00220345840630071701. [DOI] [PubMed] [Google Scholar]
  37. Ohkusa T., Yamada M., Takenaga T., Kitazume C., Yamamoto N., Sasabe M., Takashimizu I., Tamura Y., Sakamoto E., Kurosawa H. [Protective effect of metronidazole in experimental ulcerative colitis induced by dextran sulfate sodium]. Nihon Shokakibyo Gakkai Zasshi. 1987 Oct;84(10):2337–2346. [PubMed] [Google Scholar]
  38. Okayasu I., Hatakeyama S., Yamada M., Ohkusa T., Inagaki Y., Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology. 1990 Mar;98(3):694–702. doi: 10.1016/0016-5085(90)90290-h. [DOI] [PubMed] [Google Scholar]
  39. Onderdonk A. B., Bartlett J. G. Bacteriological studies of experimental ulcerative colitis. Am J Clin Nutr. 1979 Jan;32(1):258–265. doi: 10.1093/ajcn/32.1.258. [DOI] [PubMed] [Google Scholar]
  40. Onderdonk A. B., Hermos J. A., Dzink J. L., Bartlett J. G. Protective effect of metronidazole in experimental ulcerative colitis. Gastroenterology. 1978 Mar;74(3):521–526. [PubMed] [Google Scholar]
  42. Pacifici G. M., Romiti P., Santerini S., Giuliani L. S-methyltransferases in human intestine: differential distribution of the microsomal thiol methyltransferase and cytosolic thiopurine methyltransferase along the human bowel. Xenobiotica. 1993 Jun;23(6):671–679. doi: 10.3109/00498259309059404. [DOI] [PubMed] [Google Scholar]
  43. Pochart P., Doré J., Lémann F., Goderel I., Rambaud J. C. Interrelations between populations of methanogenic archaea and sulfate-reducing bacteria in the human colon. FEMS Microbiol Lett. 1992 Nov 1;77(1-3):225–228. doi: 10.1016/0378-1097(92)90160-p. [DOI] [PubMed] [Google Scholar]
  44. Potten C. S., Kellett M., Rew D. A., Roberts S. A. Proliferation in human gastrointestinal epithelium using bromodeoxyuridine in vivo: data for different sites, proximity to a tumour, and polyposis coli. Gut. 1992 Apr;33(4):524–529. doi: 10.1136/gut.33.4.524. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Roediger W. E., Duncan A., Kapaniris O., Millard S. Reducing sulfur compounds of the colon impair colonocyte nutrition: implications for ulcerative colitis. Gastroenterology. 1993 Mar;104(3):802–809. doi: 10.1016/0016-5085(93)91016-b. [DOI] [PubMed] [Google Scholar]
  46. Roediger W. E., Nance S. Metabolic induction of experimental ulcerative colitis by inhibition of fatty acid oxidation. Br J Exp Pathol. 1986 Dec;67(6):773–782. [PMC free article] [PubMed] [Google Scholar]
  47. Roediger W. E. Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man. Gut. 1980 Sep;21(9):793–798. doi: 10.1136/gut.21.9.793. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Roediger W. E. The colonic epithelium in ulcerative colitis: an energy-deficiency disease? Lancet. 1980 Oct 4;2(8197):712–715. doi: 10.1016/s0140-6736(80)91934-0. [DOI] [PubMed] [Google Scholar]
  49. Roediger W. E. Utilization of nutrients by isolated epithelial cells of the rat colon. Gastroenterology. 1982 Aug;83(2):424–429. [PubMed] [Google Scholar]
  50. Sadlack B., Merz H., Schorle H., Schimpl A., Feller A. C., Horak I. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell. 1993 Oct 22;75(2):253–261. doi: 10.1016/0092-8674(93)80067-o. [DOI] [PubMed] [Google Scholar]
  51. Scheppach W., Sommer H., Kirchner T., Paganelli G. M., Bartram P., Christl S., Richter F., Dusel G., Kasper H. Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis. Gastroenterology. 1992 Jul;103(1):51–56. doi: 10.1016/0016-5085(92)91094-k. [DOI] [PubMed] [Google Scholar]
  52. Segal I. Ulcerative colitis in a developing country of Africa: the Baragwanath experience of the first 46 patients. Int J Colorectal Dis. 1988 Nov;3(4):222–225. doi: 10.1007/BF01660719. [DOI] [PubMed] [Google Scholar]
  53. Senagore A. J., MacKeigan J. M., Scheider M., Ebrom J. S. Short-chain fatty acid enemas: a cost-effective alternative in the treatment of nonspecific proctosigmoiditis. Dis Colon Rectum. 1992 Oct;35(10):923–927. doi: 10.1007/BF02253492. [DOI] [PubMed] [Google Scholar]
  54. Shields R. Presidential review of the year's activity 1990-91. Gut. 1992 Apr;33(4):569–571. doi: 10.1136/gut.33.4.569. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Staerk Laursen L., Stokholm M., Bukhave K., Rask-Madsen J., Lauritsen K. Disposition of 5-aminosalicylic acid by olsalazine and three mesalazine preparations in patients with ulcerative colitis: comparison of intraluminal colonic concentrations, serum values, and urinary excretion. Gut. 1990 Nov;31(11):1271–1276. doi: 10.1136/gut.31.11.1271. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Stein J., Schröder O., Milovic V., Caspary W. F. Mercaptopropionate inhibits butyrate uptake in isolated apical membrane vesicles of the rat distal colon. Gastroenterology. 1995 Mar;108(3):673–679. doi: 10.1016/0016-5085(95)90438-7. [DOI] [PubMed] [Google Scholar]
  57. Strocchi A., Ellis C. J., Furne J. K., Levitt M. D. Study of constancy of hydrogen-consuming flora of human colon. Dig Dis Sci. 1994 Mar;39(3):494–497. doi: 10.1007/BF02088333. [DOI] [PubMed] [Google Scholar]
  58. Vernia P., Marcheggiano A., Caprilli R., Frieri G., Corrao G., Valpiani D., Di Paolo M. C., Paoluzi P., Torsoli A. Short-chain fatty acid topical treatment in distal ulcerative colitis. Aliment Pharmacol Ther. 1995 Jun;9(3):309–313. doi: 10.1111/j.1365-2036.1995.tb00386.x. [DOI] [PubMed] [Google Scholar]
  59. Watford M., Lund P., Krebs H. A. Isolation and metabolic characteristics of rat and chicken enterocytes. Biochem J. 1979 Mar 15;178(3):589–596. doi: 10.1042/bj1780589. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Weber P., Koch M., Heizmann W. R., Scheurlen M., Jenss H., Hartmann F. Microbic superinfection in relapse of inflammatory bowel disease. J Clin Gastroenterol. 1992 Jun;14(4):302–308. doi: 10.1097/00004836-199206000-00008. [DOI] [PubMed] [Google Scholar]
  61. Weisiger R. A., Pinkus L. M., Jakoby W. B. Thiol S-methyltransferase: suggested role in detoxication of intestinal hydrogen sulfide. Biochem Pharmacol. 1980 Oct 15;29(20):2885–2887. doi: 10.1016/0006-2952(80)90029-5. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES